{
  "ticker": "ATX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972787",
  "id": "02972787",
  "pages": 39,
  "price_sensitive": false,
  "date": "20250725",
  "time": "1446",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250725/pdf/06m4mttb5ctb1v.pdf",
  "summary": "### **Material Information Summary**  \n\n#### **Capital Raising Announcement**  \n- **Structure**: Multi-component capital raise totaling **A$27.5M**, comprising:  \n  - **Placement**: **A$22.3M** (96,804,354 shares at **A$0.23/share**).  \n    - **Already issued**: 57,937,087 shares under ASX LR 7.1 (ratification sought via **Resolution 8**).  \n    - **Pending**: 38,867,267 shares under ASX LR 7.1A (not requiring ratification).  \n  - **Share Purchase Plan (SPP)**: Up to **A$10M** (max **55.6M shares** if price = A$0.18). Approval sought via **Resolution 9**.  \n  - **Conditional Placement**: **A$2.5M** (10,869,566 shares at A$0.23). Approval sought via **Resolution 15**.  \n  - **Director Placement**: **A$235,000** (1,021,740 shares at A$0.23). Approvals sought via **Resolutions 10\u201313**.  \n\n- **Use of Funds**: Phase 2a/2b/3 ACCENT trial, AMPLICITY/KRAS/Ovarian trials, manufacturing, working capital.  \n\n- **Key Dates**:  \n  - **SPP Open/Close**: 1 Aug \u2013 22 Aug 2025.  \n  - **AGM**: 27 Aug 2025.  \n  - **Director/Conditional Placement Settlement**: 29 Aug 2025.  \n\n---  \n\n#### **Equity Incentive Plan (EIP)** (**Resolution 3**)  \n- **Approval sought** to issue **25.4M shares/options** (5% of post-capital raise shares) under EIP over 3 years (exempt from 15% cap under ASX LR 7.2).  \n\n---  \n\n#### **Director Remuneration (Resolutions 4\u20137)**  \n- **Options/ZEPOs issuance**:  \n  - **Non-Exec Directors**: 818,006 options (exercise price **A$0.30**, vesting over 2 years).  \n  - **MD/CEO (Dr Burns)**: 447,000 Zero-Exercise Price Options (ZEPOs, vesting over 3 years).  \n\n---  \n\n#### **10% Placement Facility Renewal** (**Resolution 14**)  \n- **Special resolution** to renew ability to issue **10% of shares** (beyond standard 15% cap) over 12 months post-AGM.  \n\n---  \n\n#### **Governance**  \n- **Re-election of Dr Warwick Tong** (**Resolution 2**).  \n- **Remuneration Report** advisory vote (**Resolution 1**).  \n\n---  \n\n**Notes**:  \n- Omitted: Routine AGM procedural items, director bios, legal boilerplate.  \n- Focus retained on liquidity, dilution, and capital structure impacts.  \n\n**Format**: Concise bullet points prioritizing tradeable/material data.",
  "usage": {
    "prompt_tokens": 27195,
    "completion_tokens": 652,
    "total_tokens": 27847,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-25T04:54:58.080170"
}